VNDA - Vanda Pharmaceuticals Inc
IEX Last Trade
5.28
0.060 1.136%
Share volume: 600,277
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.22
0.06
1.15%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-09 | 2023-05-03 | 2023-07-28 | 2023-11-09 | 2024-02-08 | 2024-05-09 | 2024-08-01 | |
| Total revenue | 65.318 M | 64.482 M | 62.498 M | 46.056 M | 38.815 M | 45.271 M | 47.462 M | 50.474 M | |
| Cost of revenue | 6.320 M | 6.238 M | 4.774 M | 3.499 M | 3.063 M | 3.460 M | 3.440 M | 2.733 M | |
| Gross profit | 58.998 M | 58.244 M | 57.724 M | 42.557 M | 35.752 M | 41.811 M | 44.022 M | 47.741 M | |
| -1.28% | -0.89% | -26.28% | -15.99% | 16.95% | 5.29% | 8.45% | |||
| Operating expenses | 54.711 M | 51.236 M | 55.341 M | 45.046 M | 41.367 M | 47.952 M | 51.239 M | 56.135 M | |
| Selling general and admin | 29.854 M | 32.782 M | 36.104 M | 28.399 M | 24.767 M | 23.613 M | 30.085 M | 39.474 M | |
| Research and development | 24.857 M | 18.454 M | 19.237 M | 16.647 M | 16.600 M | 24.339 M | 21.154 M | 16.661 M | |
| Total expenses | 61.410 M | 57.853 M | 60.494 M | 48.923 M | 44.810 M | 52.365 M | 56.697 M | 60.620 M | |
| -5.79% | 4.57% | -19.13% | -8.41% | 16.86% | 8.27% | 6.92% | |||
| Operating income | 3.908 M | 6.629 M | 2.004 M | -2.867 M | -5.995 M | -7.094 M | -9.235 M | -10.146 M | |
| Ebit | 3.908 M | 6.629 M | 2.004 M | -2.867 M | -5.995 M | -7.094 M | -9.235 M | -10.146 M | |
| Pretax income | 5.461 M | 9.613 M | 5.528 M | 2.592 M | -120.000 K | -1.661 M | -4.664 M | -5.516 M | |
| 76.03% | -42.49% | -53.11% | -104.63% | 1,284.17% | 180.79% | 18.27% | |||
| Income tax | 2.191 M | 2.752 M | 2.276 M | 1.072 M | -257.000 K | 739.000 K | -518.000 K | -998.000 K | |
| Net income basic | 3.270 M | 6.861 M | 3.252 M | 1.520 M | 137.000 K | -2.400 M | -4.146 M | -4.518 M | |
| 109.82% | -52.60% | -53.26% | -90.99% | -1,851.82% | -72.75% | -8.97% | |||
| Net income | 3.270 M | 6.861 M | 3.252 M | 1.520 M | 137.000 K | -2.400 M | -4.146 M | -4.518 M | |
| 109.82% | -52.60% | -53.26% | -90.99% | -1,851.82% | -72.75% | -8.97% |